Sertraline Hydrochloride Tablet
Product Images NDC 63187-859

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 63187-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Eca3f504 92e3 4765 B175 23cdcaf20634 01)

FDA Label Image

63187-859-30 (Eca3f504 92e3 4765 B175 23cdcaf20634 02)

63187-859-30 (Eca3f504 92e3 4765 B175 23cdcaf20634 02)
This is a description of Sertraline 25mg, a prescription medication produced by InvaGen Pharmaceuticals, Inc. The medication comes in a package of #30 tablets, each containing Sertraline hydrochloride, USP equivalent to 25mg Sertraline. The tablets are light-green, film-coated, modified, oval biconvex tablets marked with | on the left Side of the bisect and G on the right Side of the bisect on one side, and "212" on the other. This medication should be stored at 20°-25°C (68°-77°F), and should be kept out of the reach of children. The medication guide should be provided to each patient. The package includes Lot #:00000Exp. 00/00/00 and the NDC 63187-859-30 number. The product was relabeled by Proficient Rx LPlocated Thousand Oaks, CA 91320.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.